Home/Filings/4/0001144204-11-051465
4//SEC Filing

Fonstein Michael 4

Accession 0001144204-11-051465

CIK 0001318641other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 6:08 AM ET

Size

4.4 KB

Accession

0001144204-11-051465

Insider Transaction Report

Form 4
Period: 2011-09-02
Fonstein Michael
DirectorCEO, President
Transactions
  • Purchase

    Common Stock, par value $0.005 per share

    2011-09-02$2.27/sh+2,200$4,9941,253,400 total

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001369806

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:08 AM ET
Size
4.4 KB